End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118.4 CNY | +1.07% | +12.89% | -5.94% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Sales forecast by analysts have been recently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.94% | 2.57B | - | ||
+3.45% | 30.12B | B- | ||
+7.21% | 21.44B | B | ||
+10.44% | 11.49B | B- | ||
+15.39% | 5.27B | C- | ||
+16.44% | 4.38B | B+ | ||
-15.24% | 3.53B | C | ||
-0.53% | 3.24B | B+ | ||
+4.98% | 3.12B | C+ | ||
+28.84% | 2.81B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 688639 Stock
- Ratings Anhui Huaheng Biotechnology Co., Ltd.